Previous Close | 0.5200 |
Open | 0.5111 |
Bid | 0.5120 x 2200 |
Ask | 0.5300 x 1300 |
Day's Range | 0.5081 - 0.5350 |
52 Week Range | 0.2500 - 0.9100 |
Volume | |
Avg. Volume | 989,485 |
Market Cap | 35.077M |
Beta (5Y Monthly) | 1.77 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
POTOMAC, Md., April 16, 2024--IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two.
POTOMAC, Md., April 09, 2024--IGC Pharma Adds Advisor in Artificial Intelligence
POTOMAC, Md., March 26, 2024--IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock